CARD10 and cancer: While the above studies provide evidence for an intriguing link between CARMA3 expression levels and the pathogenesis of several solid tumors, it remains unclear as to whether the naturally occurring CARMA3 overexpression observed in some cancer cells is sufficient to drive dysregulated C3BM signaling, as it is when CARMA3 is artificially overexpressed in transfected cells.